HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...

HCW Biologics (HCWB) announced that it has received clearance of its Investigational New Drug Application, IND, from the U.S. Food and Drug ...

This study will evaluate HCW9302 in patients with moderate to severe alopecia areataMIRAMAR, Fla., Feb. 03, 2025 (GLOBE ...

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...

The FDA also gave its nod to Bristol Myers Squibb’s Cobenfy (xanomeline and trospium chloride), the first new class of antischizophrenia drug to be approved in decades. Roughly one-third of last ...

Kaz Crossley has shared the important reason for her new cropped hair, she has been living with alopecia and shaved her head for charity. The influencer, first appeared on Love Island back in 2018, ...

Kaz Crossley has shared the important reason for her new cropped hair, she has been living with alopecia and shaved her head for charity. The influencer, first appeared on Love Island back in 2018 ...

According to GlobalData, Phase I drugs for Alopecia Areata have an 88% phase transition success rate (PTSR) indication benchmark for progressing into Phase II. GlobalData’s report assesses how ...

There are currently no treatments available for celiac disease beyond a gluten-free diet. Several late-phase companies aim to ...

A new targeted approach, which combines a drug called encorafenib with cetuximab and chemotherapy regimen mFOLFOX6, has received accelerated FDA approval for metastatic colorectal cancer with a BRAF ...